Angelini Pharma
  • Angelini Pharma Worldwide
    • Austria
    • Bulgaria
    • Czech Republic
    • Germany
    • Greece
    • Italy
    • Nordics
    • Poland
    • Portugal
    • Romania
    • Russia
    • Slovakia
    • Spain
    • Turkey
    • United Kingdom
  • Angelini Pharma
  • Who we are

    • About us
    • What we do
    • Vision, mission & values
    • Key facts and events
    • People
  • Core areas

    • Brain Health
    • Consumer Health
  • From pipeline to health aids

    • Pipeline
    • Sites
  • Our Partnerships

    • Research & Academic Centers and Scientific Institutions
    • Partnering
    • Independent Research (IIT/RIS)
  • Our Responsibility

    • Sustainability
    • Projects
    • Diversity & Inclusion
    • Ethics
    • Quality & EHS
    • Transparency
  • Media

    • News
    • Press releases
    • Press kit
    • Magazine
    • Media center
  • Career Opportunities
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. Our responsibility
  3. Transparency
  4. Netherlands

Netherlands

Angelini Pharma France SAS has fulfilled reporting obligations per local requirements. Disclosures are available on the Foundation for the Code for Pharmaceutical Advertising (CGR) website: Stichting Transparantieregister Zorg - Home. Inquiries may be submitted to quality_netherlands@angelinipharma.com.

 

2021

Netherlands - Transparency Report

Share

  • Twitter
  • Facebook
  • Linkedin
  • Top Employer Europe 2023
  • Terms of use
  • Privacy
  • Transparency
  • Cookie Policy
  • Contact
  • Accessibility declaration
  • Site map
  • Credits
  • Cookie settings
  • Twitter
  • Linkedin
  • Facebook
  • Instagram
  • YouTube

Angelini Pharma S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2023 © Angelini S.p.a. - All Rights Reserved

Part of Angelini Industries

Close menu